-
It is not current practice in most EDs, and it is not without controversy. In fact, one ethicist has called the practice "ghoulish." However, a government-funded pilot program at University of Pittsburgh Medical Center (UPMC) Presbyterian Hospital and Allegheny General Hospital, both in Pittsburgh, is seeking to make organ donation from the ED a reality, while at the same time addressing the ethical challenges that have been raised and the logistical challenges that can lower the odds for success.
-
A program designed to find a "medical home" for complex pediatric patients can reduce the number of ED visits by 55%, according to a study published in the March 11, 2010, online edition of the Journal of Pediatrics.
-
In most EDs, the last thing a provider wants is an extra, non-clinical individual "getting in the way."
-
EDs at a number of Hospital Corporation of America (HCA) hospitals in the Southeast are using "new media" to inform patients of their average wait times over the past several hours. These times have been posted on hospital web sites, digital billboards, and most recently, via text messaging.
-
[Editor's note: This article is the first in a two-part series on preventing violence. In this story we examine the keys to a zero tolerance policy. In next month's issue, we will discuss key recommendations from the Occupational Safety and Health Administration and the importance of communicating effectively with patients and their families.]
-
Consensus guidelines recommend the use of either dopamine or norepinephrine as first-line therapy for patients with shock, but recent observational evidence suggests norepinephrine may be associated with better outcomes.
-
Intensive care practitioners are constantly faced with questions about their patients' hemodynamic issues, including the volume status, fluid responsiveness, and the need for vasopressors or inotropic support.
-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
-
Casey and colleagues compared the effects on pain, level of consciousness, and vital signs of 2 different doses of remifentanil and placebo for removal of chest drains after cardiac surgery in 60 patients.
